Growth factor delivery-based tissue engineering: general approaches and a review of recent developments

被引:1011
作者
Lee, Kangwon [1 ,2 ]
Silva, Eduardo A. [2 ]
Mooney, David J. [1 ,2 ]
机构
[1] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02139 USA
[2] Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02139 USA
基金
美国国家卫生研究院;
关键词
regenerative medicine; biomaterials; synthetic extracellular matrix; stimuli-responsive materials; nanoparticles; BONE MORPHOGENETIC PROTEIN-2; SEQUENTIAL BMP-2/BMP-7 DELIVERY; CORONARY-ARTERY-DISEASE; PH-SENSITIVE HYDROGELS; ILIAC CREST AUTOGRAFT; CONTROLLED-RELEASE; THERAPEUTIC ANGIOGENESIS; EXTRACELLULAR-MATRIX; SUSTAINED-RELEASE; CELL-ADHESION;
D O I
10.1098/rsif.2010.0223
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The identification and production of recombinant morphogens and growth factors that play key roles in tissue regeneration have generated much enthusiasm and numerous clinical trials, but the results of many of these trials have been largely disappointing. Interestingly, the trials that have shown benefit all contain a common denominator, the presence of a material carrier, suggesting strongly that spatio-temporal control over the location and bioactivity of factors after introduction into the body is crucial to achieve tangible therapeutic effect. Sophisticated materials systems that regulate the biological presentation of growth factors represent an attractive new generation of therapeutic agents for the treatment of a wide variety of diseases. This review provides an overview of growth factor delivery in tissue engineering. Certain fundamental issues and design strategies relevant to the material carriers that are being actively pursued to address specific technical objectives are discussed. Recent progress highlights the importance of materials science and engineering in growth factor delivery approaches to regenerative medicine.
引用
收藏
页码:153 / 170
页数:18
相关论文
共 197 条
[51]   Biodegradable thermosensitive injectable PEG-PCL-PEG hydrogel for bFGF antigen delivery to improve humoral immunity [J].
Gong, Chang-Yang ;
Shi, Shuai ;
Peng, Xin-Yun ;
Kan, Bing ;
Yang, Li ;
Huang, Mei-Juan ;
Luo, Feng ;
Zhao, Xia ;
Wei, Yu-Quan ;
Qian, Zhi-Yong .
GROWTH FACTORS, 2009, 27 (06) :377-383
[52]   Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures -: A prospective, controlled, randomized study of four hundred and fifty patients [J].
Govender, S ;
Csimma, C ;
Genant, HK ;
Valentin-Opran, A ;
Amit, Y ;
Arbel, R ;
Aro, H ;
Atar, D ;
Bishay, M ;
Börner, MG ;
Chiron, P ;
Choong, P ;
Cinats, J ;
Courtenay, B ;
Feibel, R ;
Geulette, B ;
Gravel, C ;
Haas, N ;
Raschke, M ;
Hammacher, E ;
van der Velde, D ;
Hardy, P ;
Holt, M ;
Josten, C ;
Ketterl, RL ;
Lindeque, B ;
Lob, G ;
Mathevon, H ;
Mccoy, G ;
Marsh, D ;
Miller, R ;
Munting, E ;
Oevre, S ;
Nordsletten, L ;
Patel, A ;
Pohl, A ;
Rennie, W ;
Reynders, P ;
Rommens, PM ;
Rondia, J ;
Rossouw, WC ;
Daneel, PJ ;
Ruff, S ;
Rüter, A ;
Santavirta, S ;
Schildhauer, TA ;
Gekle, C ;
Schnettler, R ;
Segal, D ;
Seiler, H .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2002, 84A (12) :2123-2134
[53]   Integrin signalling during tumour progression [J].
Guo, WJ ;
Giancotti, FG .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (10) :816-826
[54]   Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord [J].
Gupta, D ;
Tator, CH ;
Shoichet, MS .
BIOMATERIALS, 2006, 27 (11) :2370-2379
[55]   Synthesis and characterization of injectable, thermally and chemically gelable, amphiphilic poly(N-isopropylacrylamide)-based macromers [J].
Hacker, Michael C. ;
Klouda, Leda ;
Ma, Brandy B. ;
Kretlow, James D. ;
Mikos, Antonicis G. .
BIOMACROMOLECULES, 2008, 9 (06) :1558-1570
[56]   Matnix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating αvβ3-integrin and activating VEGF-R2 [J].
Hall, H ;
Hubbell, JA .
MICROVASCULAR RESEARCH, 2004, 68 (03) :169-178
[57]   Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord [J].
Hamann, MCJ ;
Tator, CH ;
Shoichet, MS .
EXPERIMENTAL NEUROLOGY, 2005, 194 (01) :106-119
[58]   Novel intrathecal delivery system for treatment of spinal cord injury [J].
Hamann, MCJ ;
Tsai, EC ;
Tator, CH ;
Shoichet, MS .
EXPERIMENTAL NEUROLOGY, 2003, 182 (02) :300-309
[59]  
Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO
[60]  
2-E